Assenagon Asset Management S.A. Raises Holdings in Intuitive Surgical, Inc. $ISRG

Assenagon Asset Management S.A. increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.8% during the 1st quarter, Holdings Channel reports. The fund owned 1,745,008 shares of the medical equipment provider’s stock after purchasing an additional 211,237 shares during the quarter. Intuitive Surgical makes up about 1.2% of Assenagon Asset Management S.A.’s investment portfolio, making the stock its 12th largest position. Assenagon Asset Management S.A.’s holdings in Intuitive Surgical were worth $804,431,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of ISRG. Holos Integrated Wealth LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $25,000. Newbridge Financial Services Group Inc. grew its stake in shares of Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares during the period. Olistico Wealth LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $28,000. Caitlin John LLC purchased a new position in shares of Intuitive Surgical during the 3rd quarter valued at approximately $30,000. Finally, Laurel Wealth Advisors LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $31,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on ISRG. Robert W. Baird increased their price target on shares of Intuitive Surgical from $575.00 to $610.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. BTIG Research reaffirmed a “buy” rating and issued a $574.00 price objective on shares of Intuitive Surgical in a report on Wednesday, April 22nd. UBS Group decreased their price objective on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research report on Tuesday, March 17th. Jefferies Financial Group lowered their target price on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating on the stock in a research note on Wednesday, April 22nd. Finally, Deutsche Bank Aktiengesellschaft cut their price target on Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating for the company in a research note on Tuesday, June 2nd. Nineteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $573.42.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Iman Jeddi sold 5,625 shares of Intuitive Surgical stock in a transaction on Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the sale, the senior vice president owned 6,463 shares of the company’s stock, valued at $2,718,014.65. The trade was a 46.53% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total transaction of $169,656.00. Following the sale, the executive vice president directly owned 5,720 shares of the company’s stock, valued at $2,426,080.80. The trade was a 6.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 7,169 shares of company stock valued at $3,059,135. 0.60% of the stock is owned by insiders.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical raised its 2026 outlook after strong first-quarter results, with management increasing da Vinci procedure growth guidance to 13.5%-15.5% from 13%-15%, signaling continued adoption of its robotic surgery platform. Article Title
• Positive Sentiment: Recent commentary suggests the stock may be undervalued after its recent share-price weakness, with some analysis arguing the pullback has reset expectations and could improve long-term upside potential. Article Title
• Neutral Sentiment: ISRG has been a trending stock among investors, which shows elevated attention but does not by itself change the company’s fundamentals. Article Title
• Neutral Sentiment: Some investors are viewing Intuitive Surgical as a hedge against market risk, reflecting the company’s perceived defensive qualities and durable medical-device business model. Article Title
• Negative Sentiment: Jim Cramer said Intuitive Surgical faces “too much competition,” reinforcing investor concerns that rivals could pressure the company’s leadership position and future growth. Article Title
• Negative Sentiment: Additional articles highlighted recent stock weakness, valuation concerns, FDA scrutiny, product recalls, leadership changes, and a bearish Deutsche Bank price target cut to $366, all of which could be weighing on sentiment. Article Title

Intuitive Surgical Trading Up 0.1%

NASDAQ:ISRG opened at $403.18 on Wednesday. The stock has a 50 day moving average of $436.44 and a two-hundred day moving average of $487.58. Intuitive Surgical, Inc. has a 12 month low of $396.68 and a 12 month high of $603.88. The firm has a market cap of $142.79 billion, a P/E ratio of 48.87, a price-to-earnings-growth ratio of 3.28 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. The business had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business’s quarterly revenue was up 23.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.81 earnings per share. On average, research analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.